Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter

June 13, 2019 updated by: Yonsei University

Retrievability and Incidence of Complex Retrieval in Celect Versus Denali Filter: A Prospective, Randomized, Comparative Study

The primary purpose of this study is to compare the Celect and Denali filters in terms of complicated filter retrieval and indwelling complications after a 2-month indwelling time.

Study Overview

Status

Unknown

Detailed Description

With anticoagulation being the standard treatment for deep venous thrombosis and pulmonary embolism, inferior vena cava filter placement plays an important role in patients who are amenable to anticoagulant therapy. Currently, many different types of retrievable filters are being used in clinical practice and the choice of the filters depends on operators' preference and institutional availability. Each filter has different designs to maximize retrievability and minimize indwelling complications. Up until now, the prior studies on the filter retrievability and indwelling complications have been retrospective in nature and had relatively long dwell times. Comparative data regarding the retrievability of the inferior vena cava filters may help to choose filter selection. Therefore, the aim of this trial is to compare two commonly used inferior vena cava filters (Denali and Celet filters)

Study Type

Interventional

Enrollment (Anticipated)

174

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Seoul, Korea, Republic of
        • Recruiting
        • Department of Radiology, Severance hospital, Yonsei College of Medicine
        • Contact:
          • Man Deuk Kim, MD, Ph.D
          • Phone Number: 82-2-2228-7400
          • Email: mdkim@yuhs.ac

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 1. Patients who develop deep venous thrombosis and/or pulmonary embolism but are good candidates for anticoagulant therapy
  • 2. Inferior vena cava filtration before mechanical thrombectomy for deep venous thrombosis
  • 3. Prophylactic filter placement because of trauma or major surgery

Exclusion Criteria:

  • 1. Sepsis
  • 2. Those who need permanent filter placement
  • 3. Congenital anatomical anomaly (IVC duplication, interrupted IVC)
  • 4. patients who need filter placement in the suprarenal inferior vena cava

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: TREATMENT
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: SINGLE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Denali Group
Those who received Denali filter placement
Patients who are enrolled in this study are assigned to receive either Denali or Celect filter in the inferior vena cava. All other procedures are the same in both groups
EXPERIMENTAL: Celect Group
Those who received Celect filter placement
Patients who are enrolled in this study are assigned to receive either Denali or Celect filter in the inferior vena cava. All other procedures are the same in both groups

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of complicated filter retrieval
Time Frame: 2 months after filter placement
Incidence of retrieval cases that require the use of standard retrieval kit (sheath and snare)
2 months after filter placement

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Incidence of penetration
Time Frame: 2 months after filter placement
2 months after filter placement
tilt angle
Time Frame: 2 months after filter placement
2 months after filter placement
Filter migration
Time Frame: 2 months after filter placement
Filter migration is a change in filter position com-pared with its deployed position (cranial or caudal) of more than 2 cm as documented by diagnostic imaging.
2 months after filter placement
fracture
Time Frame: 2 months after filter placement
Filter fracture is any loss of a filter's structural integrity(ie, breakage or separation) documented by imaging.
2 months after filter placement
signs of inferior vena cava occlusion/stenosis
Time Frame: 2 months after filter placement
Any signs of narrowing or obstruction of the IVC where the IVC filter was inserted as documented by CT.
2 months after filter placement

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ANTICIPATED)

July 1, 2019

Primary Completion (ANTICIPATED)

May 1, 2020

Study Completion (ANTICIPATED)

June 1, 2020

Study Registration Dates

First Submitted

May 26, 2019

First Submitted That Met QC Criteria

June 13, 2019

First Posted (ACTUAL)

June 17, 2019

Study Record Updates

Last Update Posted (ACTUAL)

June 17, 2019

Last Update Submitted That Met QC Criteria

June 13, 2019

Last Verified

June 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe